Advancing Care in HR+/HER2- BC: From Node-Positive High-Rish EBC to MBC

Overview

Breast cancer management continues to evolve rapidly, particularly in patients with HR+/HER2− disease across early and metastatic settings. This scientific broadcast aims to highlight recent advances in the treatment continuum, with a specific focus on node-positive high-risk early breast cancer (EBC) and the transition to metastatic breast cancer (MBC).

This Activity for

• Resident / Fellow
• Physician
• Clinical Pharmacy

What I will learn?

To enhance healthcare professionals’ understanding and practical application of current evidence in the management of HR+/HER2− breast cancer across early and metastatic settings, with a focus on optimizing treatment decisions for node positive high risk early breast cancer and disease progression to metastatic breast cancer.

About Organizer

• Virtual Medical Academy

Additional items to the activity

Optional Details	Type	Fee
Advancing Care in HR+/HER2- BC: From Node-Positive High-Rish EBC to MBC Certificate	Certificate	Free

VAT 15% Included